Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Insulin drugs could lose $6.1B to biosimilars
Insulin drugs could lose $6.1B to biosimilars
Insulin drugs could lose $6.1B to biosimilars
Submitted by
admin
on October 14, 2009 - 8:31pm
Source:
Fierce Pharma
News Tags:
insulin
biosimilars
generics
diabetes
Headline:
Insulin drugs could lose $6.1B to biosimilars
Do Not Allow Advertisers to Use My Personal information
